The MentalPlus® for Assessment and Rehabilitation of Cognitive Function After Remission of the Symptoms of COVID-19
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cognitive Dysfunction
- Cognitive Impairment
- COVID-19
- Depression, Anxiety
- Quality of Life
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: The study has two groups. The Study Group will be the group that was remissive for COVID-19 and has some of the mentioned comorbidities, even if controlled by drugs or treatments. The Control Group will be the group with remissive patients without the aforementioned comorbidities. We will assess whether comorbidities can worsen the impairment of cognitive functions after the remission of the symptoms of COVID-19. The purpose of the research is to verify; whether COVID-19 alone in moderate to severe cases causes cognitive impairment or whether predisposing factors for such comorbidities would cause further impairment in cognitive functions after COVID-19 contraction and remission.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 8 years and 88 years
- Gender
- Both males and females
Description
Subjects who contracted COVID-19 and present remission of symptoms will be studied, with different age groups, illiterate or literate, of both genders and with different socio-demographic characteristics. The volunteers will be submitted to the application of MentalPlus® to assess cognitive function...
Subjects who contracted COVID-19 and present remission of symptoms will be studied, with different age groups, illiterate or literate, of both genders and with different socio-demographic characteristics. The volunteers will be submitted to the application of MentalPlus® to assess cognitive functions and SF-8® to assess Quality of Life.
Tracking Information
- NCT #
- NCT04632719
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Livia S. Valentin, Ph.D University of Sao Paulo School of Medicine Principal Investigator: Luiz Antonio M Cesar, Ph.D University of Sao Paulo School of Medicine Principal Investigator: Luiz Aparecido Bortolotto, Ph.D University of Sao Paulo School of Medicine
Get Well Soon